Abstract
The Cancer Institute (UPCI) at the University of Pittsburgh Medical Center (UPMC) contains two cellular therapy laboratories: the Hematopoietic Stem Cell Laboratory (HSC Lab) and Cellular Products Laboratory/Gene Therapy Laboratory (CPL/GTL). These facilities are responsible for the final development and manufacturing of biological products required for University investigator-initiated research protocols, external partnerships, and contracts for cellular product manufacturing. This chapter describes the design features of these two laboratories.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Donnenberg AD. Good Manufacturing Practices (GMP) in a Hospital Environment: The Ideal and the Real. Cytotherapy. 2001; 3(2): 63–5.
McCullough J, Wagner J, Gee A, Rooney C, Whiteside T, Donnenberg A, Lindblad R. Production Assistance for Cellular Therapies. Transfusion. 2004; 44(12): 1793–5.
Donnenberg AD, Koch EK, Griffin DL, Stanczak HM, Kiss JE, Carlos TM, BuchBarker DM, Yeager AM. Viability of Cryopreserved Bone Marrow (BM) Progenitor Cells Stored for More Than a Decade. Cytotherapy. 2002; 4(2): 157–63.
Whiteside TL. Anti Tumor Vaccines in Head and Neck Cancer: Targeting Immune Responses to the Tumor. Curr Cancer Drug Targets. 2007 Nov; 7(7): 633–42. Review.
Okada H, Lieberman FS, Walter KA, Lunsford LD, Kondziolka DS, Bejjani GK, Hamilton RL, Torres-Trejo A, Kalinski P, Cai Q, Mabold JL, Edington HD, Butterfield LH, Whiteside TL, Potter DM, Schold SC Jr, Pollack IF. Autologous Glioma Cell Vaccine Admixed with Interleukin-4 Gene Transfected Fibroblasts in the Treatment of Patients with Malignant Gliomas. J Transl Med. 2007 Dec 19; 5: 67.
Whiteside TL. Immune Monitoring of Clinical Trials with Biotherapies. Adv Clin Chem. 2008; 45: 75–97.
Whiteside TL. Evaluation of Dendritic Cell Products Generated for Human Therapy and Post- Treatment Immune Monitoring. BioPharm Int Suppl. Advances in Vaccine Development & Manufacturing. 2008 March; 21: 2–17.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Griffin, D., Donnenberg, A., Whiteside, T. (2009). University of Pittsburgh Cancer Institute - Hematopoietic Stem Cell Laboratory (HSC Lab)/Immunological Monitoring and Cellular Products Laboratory (IMCPL). In: Gee, A. (eds) Cell Therapy. Springer, Boston, MA. https://doi.org/10.1007/b102110_5
Download citation
DOI: https://doi.org/10.1007/b102110_5
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-89583-3
Online ISBN: 978-0-387-89584-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)